A new, high-resolution image of the nuclear pore structure could help us understand better how some diseases involving defective transportation to the nuclear pores – such as intestinal, ovarian and thyroid cancer.
The new imaging, pioneered by an Zürich University (UZH) research team headed by Professor Ohad Medaliait, gives a better picture of why certain molecules are allowed to pass through the nuclear pores while others are turned away.
“We discovered a previously unobserved structure inside the nuclear pore that forms a kind of molecular gate, which can only be opened by molecules that hold the right key,” explains Medalia.
This “molecular gate” consists of a fine lattice, which enables small molecules to slip through unobstructed.
Molecules are transported into the nucleus or from the nucleus into the cytoplasm. In a human cell, more than a million molecules are transported in this way every minute.
In the process, special pores embedded in the nucleus membrane act as transport gates. These nuclear pores are among the largest and most complex structures in the cell and comprise more than 200 individual proteins, which are arranged in a ring.
They contain a transportation channel, through which small molecules can pass unobstructed, while large molecules have to meet certain criteria to be transported.
The imaging was achieved using cryo-electron tomography – a method to render cell structures three-dimensionally visible in their natural environment in high resolution using both electron microscopy and computer imaging.
The cells are shock-frozen in liquid nitrogen at -190°C.
Read science facts, not fiction...
There’s never been a more important time to explain the facts, cherish evidence-based knowledge and to showcase the latest scientific, technological and engineering breakthroughs. Cosmos is published by The Royal Institution of Australia, a charity dedicated to connecting people with the world of science. Financial contributions, however big or small, help us provide access to trusted science information at a time when the world needs it most. Please support us by making a donation or purchasing a subscription today.